Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1α, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer

Lei Xu, Dan G. Duda, Emmanuelle di Tomaso et al.|Cancer Research|2009

Cited by 161